These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of N-terminal interferon tau mutants: P26L affords enhanced activity and lack of toxicity. Shorts LH; Dancz CE; Shupp JW; Pontzer CH Exp Biol Med (Maywood); 2004 Feb; 229(2):194-202. PubMed ID: 14734798 [TBL] [Abstract][Full Text] [Related]
5. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis. Overall ML; Hertzog PJ Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957 [TBL] [Abstract][Full Text] [Related]
6. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules. Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029 [TBL] [Abstract][Full Text] [Related]
7. N-terminal amino acids of bovine alpha interferons are relevant for the neutralization of their antiviral activity. Barreto Filho JB; Eiras PR; Golgher RR Braz J Med Biol Res; 2001 May; 34(5):663-7. PubMed ID: 11323754 [TBL] [Abstract][Full Text] [Related]
8. Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. Redlich PN; Hoeprich PD; Colby CB; Grossberg SE Proc Natl Acad Sci U S A; 1991 May; 88(9):4040-4. PubMed ID: 1708891 [TBL] [Abstract][Full Text] [Related]
9. Amino acid differences in interferon-tau (IFN-τ) of Bos taurus Coreanae and Holstein. Kang D; Ryoo S; Chung B; Lee J; Park S; Han J; Jeong S; Rho G; Hong J; Bae S; Kang T; Kim S; Kim S Cytokine; 2012 Aug; 59(2):273-9. PubMed ID: 22578803 [TBL] [Abstract][Full Text] [Related]
10. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565 [TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships in the interferon-tau (IFN-tau). Changes in receptor binding and in antiviral and antiproliferative activities resulting from site-directed mutagenesis performed near the carboxyl terminus. Li J; Roberts RM J Biol Chem; 1994 Oct; 269(40):24826-33. PubMed ID: 7929162 [TBL] [Abstract][Full Text] [Related]
12. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. Babas T; Le Grand R; Dormont D; Bahraoui E AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816 [TBL] [Abstract][Full Text] [Related]
13. Development of antibodies for studying conceptus interferons in the cow. Plante C; Hansen PJ; Mirando MA; Thatcher WW; Bazer FW J Reprod Immunol; 1990 Oct; 18(3):205-23. PubMed ID: 2266538 [TBL] [Abstract][Full Text] [Related]
14. Epitope Mapping of Neutralizing Monoclonal Antibodies to Human Interferon-γ Using Human-Bovine Interferon-γ Chimeras. Zuber B; Rudström K; Ehrnfelt C; Ahlborg N J Interferon Cytokine Res; 2016 Sep; 36(9):542-51. PubMed ID: 27336613 [TBL] [Abstract][Full Text] [Related]
15. Effects of PMA and transcription factors on ovine interferon-tau transactivation in various cell lines. Yamaguchi H; Ikeda Y; Taylor A; Katsumura M; Miyazawa T; Takahashi E; Imakawa K; Sakai S Endocr J; 1999 Jun; 46(3):383-8. PubMed ID: 10503990 [TBL] [Abstract][Full Text] [Related]
16. Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2. Kontsek P; Borecký L; Zav'yalov VP; Maiorov VA Immunol Lett; 1993 Mar; 35(3):281-4. PubMed ID: 7685736 [TBL] [Abstract][Full Text] [Related]
17. Secretion of interferon-tau by bovine embryos in long-term culture: comparison of in vivo derived, in vitro produced, nuclear transfer and demi-embryos. Stojkovic M; Büttner M; Zakhartchenko V; Riedl J; Reichenbach HD; Wenigerkind H; Brem G; Wolf E Anim Reprod Sci; 1999 Apr; 55(3-4):151-62. PubMed ID: 10379668 [TBL] [Abstract][Full Text] [Related]
18. Loss of the signature six carboxyl amino acid tail from ovine interferon-tau does not affect biological activity. Ealy AD; Alexenko AP; Keisler DH; Roberts RM Biol Reprod; 1998 Jun; 58(6):1463-8. PubMed ID: 9623607 [TBL] [Abstract][Full Text] [Related]
19. Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon tau regulation of IRF-1. Stewart MD; Choi Y; Johnson GA; Yu-Lee LY; Bazer FW; Spencer TE Biol Reprod; 2002 Feb; 66(2):393-400. PubMed ID: 11804954 [TBL] [Abstract][Full Text] [Related]
20. Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP. Nordlund MS; Fermer C; Nilsson O; Warren DJ; Paus E Tumour Biol; 2007; 28(2):100-10. PubMed ID: 17287611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]